These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Use of TAB (BCP) in the field of urology]. Inada T; Sakatoku J; Hongo H; Ebisuta K; Shimizu Y Hinyokika Kiyo; 1966 Mar; 12(3):306-17. PubMed ID: 6006675 [No Abstract] [Full Text] [Related]
6. [On the action of a new analgesic anti-inflammatory drug in some ocular diseases. Preliminary note]. Manusia M Minerva Med; 1967 Apr; 58(32):1484-6. PubMed ID: 6029514 [No Abstract] [Full Text] [Related]
7. [Effect of 5-n-butyl-l-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) on antibody formation]. Kondo M; Tsuchiya K Nihon Saikingaku Zasshi; 1966 Oct; 21(10):629-32. PubMed ID: 6009584 [No Abstract] [Full Text] [Related]
8. Mechanisms of intraocular inflammation. Molteno AC Trans Ophthalmol Soc N Z; 1980; 32():69-72. PubMed ID: 6934652 [No Abstract] [Full Text] [Related]
9. Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. II. Determination of BCP and its metabolite, 1-cyclohexyl-5-(3-hydroxybutyl)-2,4,6-trioxoperhydropyrimidine by ultraviolet absorption method. Yashiki T; Kondo T; Uda Y; Mima H Chem Pharm Bull (Tokyo); 1971 Mar; 19(3):478-86. PubMed ID: 5553047 [No Abstract] [Full Text] [Related]
10. [Pharmacological studies on 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) as an anti-inflammatory agent]. Fujimura H; Tsurumi A; Hayashi M; Ushijima M; Esaki S Nihon Yakurigaku Zasshi; 1967 Mar; 63(2):43-86. PubMed ID: 6069249 [No Abstract] [Full Text] [Related]
12. [Therapeutic effect of non-steroidal anti-inflammatory agents in eye diseases]. Hirose K; Matsuo T; Kihara H Nihon Ganka Kiyo; 1968 Oct; 19(10):969-77. PubMed ID: 4885031 [No Abstract] [Full Text] [Related]
13. [Inflammation and anti-inflammatory agents. Clinical experiences with non-steroid anti-inflammatory drugs in urology]. Shishito S; Suzuki K; Sugita A; Kato M; Onodera Y Nihon Rinsho; 1968 Jan; 26(1):125-31. PubMed ID: 5748514 [No Abstract] [Full Text] [Related]
14. [Experimental application of bucolome for inflammatory diseases in the urological field]. Sugiura H; Shimaya M Hinyokika Kiyo; 1969 May; 15(5):375-81. PubMed ID: 5816788 [No Abstract] [Full Text] [Related]
15. [1st experiences in urology with a new non-steroid anti-inflammatory agent]. Rocca Rossetti S; Oggianu F; Chierichetti S Minerva Urol; 1973; 25(6):276-84. PubMed ID: 4781118 [No Abstract] [Full Text] [Related]
16. [Effect of 5-n-butyl-l-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) on bacterial infection]. Kondo M; Yamasaki T; Tsuchiya K Nihon Saikingaku Zasshi; 1966 Dec; 21(12):715-8. PubMed ID: 6010440 [No Abstract] [Full Text] [Related]
17. [Contribution to the study of AF 864 (benzydamine) in general surgery]. Coppola M; Distasi AL Rass Int Clin Ter; 1967 Jan; 47(1):33-9. PubMed ID: 5596878 [No Abstract] [Full Text] [Related]
18. A double-blind study of fluorometholone. Knopf MM Am J Ophthalmol; 1970 Nov; 70(5):739-40. PubMed ID: 4920462 [No Abstract] [Full Text] [Related]
19. Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. 3. Gas-liquid chromatographic determination of BCP and its metabolites. Yashiki T; Uda Y; Kondo T; Mima H Chem Pharm Bull (Tokyo); 1971 Mar; 19(3):487-92. PubMed ID: 5553048 [No Abstract] [Full Text] [Related]
20. [A therapeutic combination (antibiotic, antiinflammatory) in ophthalmology]. Lequin M; Didierlaurent A; Malterre M; Sourdille P; Michaud P J Med Lyon; 1967 Dec; 48(132):1781-90. PubMed ID: 5621999 [No Abstract] [Full Text] [Related] [Next] [New Search]